Maryam Rahbaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maryam Rahbaran has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Shirin A Enger
Medical Physics Unit, McGill University, Cedars Cancer Centre, DS1.4561, 1001 boul Décarie, Montreal, Quebec, H3G 1A4, CANADA
2 shared publicationsBrian A. Bergmark
Department of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
1 shared publication- James Man Git Tsui
McGill University Health Centre, Montreal, QC, Canada
1 shared publication - Joanna Li
Medical Physics Unit, Department of Oncology, Faculty of Medicine McGill University Montréal Québec Canada
1 shared publication Kevin J. Croce
Department of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
1 shared publication- Parminder Singh Basran
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105858
Retrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging
- 23 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105858
Open AccessRetrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging
- Open Access
- 9 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (24) , 245003
Dosimetric characterization of a 90 Sr 90 Y Pterygium applicator with radiochromic film and Monte Carlo Simulations
Objective . β -emitting radionuclides, such as 90 Sr 90 Y, are widely used in clinical settings for the treatment of both benign and malignant lesions, particularly as surface applicators. Despite their clinical relevance, the three-dimensional dose distributions delivered by these applicators remain inadequately characterized using Monte Carlo simulations, the current gold standard for dose calculation. This study aims to address these limitations by characterizing the three-dimensional dose distribution of a commonly used 90 Sr 90 Y Pterygium applicator. The goals include generating accurate percent-depth-dose (PDD) curves and validating a custom irradiation setup using radiochromic film and Monte Carlo simulations to enable accessible, reproducible, and highly precise radiobiology experiments. Approach . A Monte Carlo dose calculation software based on Geant4 10.02.p02 was developed, and the Amersham SIA 20 Pterygium applicator, a stacked film setup with 30 EBT-XD GafChromic ® films, and a film-cell irradiation setup (a film layer, cell monolayer, and growth media) were modeled. The dose rate was averaged over the 8.2 mm diameter active area on the surface in water in both the stacked film setup and the film-cell setup. The spectrum of the source was also calculated. An experimental PDD was generated by irradiating stacked films and was compared to the Monte Carlo simulations. Main results . The measured and computed PDDs agreed within 2% within 2.6 mm of depth. The dose rates were 28.30, 26.48, 21.23, and 22.76 cGy s −1 on the surface in water, in the film active layer, in the cell monolayer, and in the growth media, respectively, compared to the manufacturer’s nominal value of 27 cGy s −1 . Significance . A Monte Carlo-validated PDD curve of the source was generated in a stacked film setup using EBT-XD GafChromic ® film. A custom film-cell irradiation setup was characterized for future radiobiology experiments.
- 9 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (24) , 245003
Open AccessDosimetric characterization of a 90 Sr 90 Y Pterygium applicator with radiochromic film and Monte Carlo Simulations
Objective . β -emitting radionuclides, such as 90 Sr 90 Y, are widely used in clinical settings for the treatment of both benign and malignant lesions, particularly as surface applicators. Despite their clinical relevance, the three-dimensional dose distributions delivered by these applicators remain inadequately characterized using Monte Carlo simulations, the current gold standard for dose calculation. This study aims to address these limitations by characterizing the three-dimensional dose distribution of a commonly used 90 Sr 90 Y Pterygium applicator. The goals include generating accurate percent-depth-dose (PDD) curves and validating a custom irradiation setup using radiochromic film and Monte Carlo simulations to enable accessible, reproducible, and highly precise radiobiology experiments. Approach . A Monte Carlo dose calculation software based on Geant4 10.02.p02 was developed, and the Amersham SIA 20 Pterygium applicator, a stacked film setup with 30 EBT-XD GafChromic ® films, and a film-cell irradiation setup (a film layer, cell monolayer, and growth media) were modeled. The dose rate was averaged over the 8.2 mm diameter active area on the surface in water in both the stacked film setup and the film-cell setup. The spectrum of the source was also calculated. An experimental PDD was generated by irradiating stacked films and was compared to the Monte Carlo simulations. Main results . The measured and computed PDDs agreed within 2% within 2.6 mm of depth. The dose rates were 28.30, 26.48, 21.23, and 22.76 cGy s −1 on the surface in water, in the film active layer, in the cell monolayer, and in the growth media, respectively, compared to the manufacturer’s nominal value of 27 cGy s −1 . Significance . A Monte Carlo-validated PDD curve of the source was generated in a stacked film setup using EBT-XD GafChromic ® film. A custom film-cell irradiation setup was characterized for future radiobiology experiments.
- Open Access
- 3 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (13) , 135011
Monte Carlo-based dosimetry and optimization of a custom alpha cell irradiation setup
Objective. When combined with targeting agents, α-particle-emitting radionuclides show promise in treating hypoxic tumors and micrometastases. These radionuclides exhibit a high relative biological effectiveness (RBE), attributed to their high linear energy transfer, and induce complex DNA damage within targeted cells. However, most clinical experience and radiobiological data are derived from photon irradiation. To optimize α-particle-based treatments, further research is needed to refine their RBE estimates. This study aimed to characterize and optimize a custom in-vitro cell irradiation setup for α-particle RBE studies using 241Am through Monte Carlo simulations. Approach. A Geant4-based Monte Carlo simulation model was used to simulate a custom cell well setup. An 241Am (48 kBq) source was positioned beneath the well with an adjustable source-to-surface distance (SSD). The spectra of decay products was calculated with 6.5 × 10 9 simulated 241Am decay events. Simulations were conducted for SSD values of 2 mm, 5 mm, and 7 mm under three scenarios: (A) total dose rate from all decay products, (B) excluding γ-emissions, and (C) excluding secondary particles. Results were compared to published spectra and a published dose rate (0.1 Gy min−1) as validation. Main results. The validation dose rate was 0.1136 Gy min−1. Photons of 13.9–59.5 keV and α-particles of 5.39–5.48 MeV were observed. The dose inhomogeneity across the cells was around 30%, 10%, and 5% in the 2, 5, and 7 mm SSD setups, respectively. The corresponding total dose rates in cells for the three SSDs were 0.583, 0.146, and 0.0830 Gy min−1. The dose rate contributions were 90% from α-particles, less than 0.07% from γ-emissions, and 9%–10% from secondary particles. Significance. To accurately assess radiobiological effects, it is important to consider the full decay spectrum of radionuclides and their secondary particles in dosimetry calculations. These findings will aid in refining experimental setups for future in-vitro studies, contributing to more reliable RBE calculations.
- 3 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (13) , 135011
Open AccessMonte Carlo-based dosimetry and optimization of a custom alpha cell irradiation setup
Objective. When combined with targeting agents, α-particle-emitting radionuclides show promise in treating hypoxic tumors and micrometastases. These radionuclides exhibit a high relative biological effectiveness (RBE), attributed to their high linear energy transfer, and induce complex DNA damage within targeted cells. However, most clinical experience and radiobiological data are derived from photon irradiation. To optimize α-particle-based treatments, further research is needed to refine their RBE estimates. This study aimed to characterize and optimize a custom in-vitro cell irradiation setup for α-particle RBE studies using 241Am through Monte Carlo simulations. Approach. A Geant4-based Monte Carlo simulation model was used to simulate a custom cell well setup. An 241Am (48 kBq) source was positioned beneath the well with an adjustable source-to-surface distance (SSD). The spectra of decay products was calculated with 6.5 × 10 9 simulated 241Am decay events. Simulations were conducted for SSD values of 2 mm, 5 mm, and 7 mm under three scenarios: (A) total dose rate from all decay products, (B) excluding γ-emissions, and (C) excluding secondary particles. Results were compared to published spectra and a published dose rate (0.1 Gy min−1) as validation. Main results. The validation dose rate was 0.1136 Gy min−1. Photons of 13.9–59.5 keV and α-particles of 5.39–5.48 MeV were observed. The dose inhomogeneity across the cells was around 30%, 10%, and 5% in the 2, 5, and 7 mm SSD setups, respectively. The corresponding total dose rates in cells for the three SSDs were 0.583, 0.146, and 0.0830 Gy min−1. The dose rate contributions were 90% from α-particles, less than 0.07% from γ-emissions, and 9%–10% from secondary particles. Significance. To accurately assess radiobiological effects, it is important to consider the full decay spectrum of radionuclides and their secondary particles in dosimetry calculations. These findings will aid in refining experimental setups for future in-vitro studies, contributing to more reliable RBE calculations.